Bio B2B 〉 Selective Search Results
Your Selection Setting ：APIs & Intermediate；
Selective Search Results :
Biotech Companies 9 record(s)；
EirGenix is a Biologic Drug Development Company, and a Contract Development and Manufacturing Organization (CDMO). Current pipelines involve seven products in development ranging from discovery to clinical, such as HER2 family biosimilars, antibody-drug conjugates (ADCs), and carrier protein for vaccine therapy.EirGenix provides high quality and cost-effective service, supporting our clients
INNOPHARMAX is a specialty pharmaceutical company focused in the development and commercialization of products for the treatment of oncology and specialty. We internally develop and/or acquire potential drug candidates for further clinical development as well as commercialization. We intend to use internally developed drug delivery technology platforms for improving the safety and efficacy
Syn-Tech Chem. & Pharm. Co., Ltd.
Syn-Tech was established in 1982 as a professional APIs manufacturer.In the past decades, all the employees in Syn-Tech followed the philosophy of honesty, sincerity, innovation and development to create a good reputed company in APIs industry. We experienced the processes of all systems such as a ISO, OHSAS, GMP and PIC/s GMP. We also participate all kind of audits from authorities and
Formosa Laboratories, Inc
Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosa's major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol
Oneness Biotech Co., Ltd.
We began in 2008 as a government-approved biopharmaceutical company devoted to New Drug Development. In 2011, Oneness became a listed company on the over-the-counter market in Taiwan under the approval of the Securities and Futures Bureau.Today, our vision, our mission and our strategy identify who we are as a company at Oneness.Our VisionOur goal is to become a leading international biotech
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
ScinoPharm Taiwan, Ltd.
Founded in 1997, with initial on-site operations beginning in November 1999, ScinoPharm offers a wide array of process R&D services and API manufacturing capabilities designed to satisfy customers' exact requirements and facilitate their rapid market introductions. ScinoPharm specializes in process R&D and the production of CGMP Active Pharmaceutical Ingredients (APIs).ScinoPharm targets
SCI Pharmtech, Inc.
SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and customproducts.Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effectiveproduction
GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.
Gwo Xi Company was founded in 2004. We are developing stem cell therapies that have the potential to transform the lives of people with degeneration diseases and rare diseases. Our production platform is fully compliant with medical regulations (GTP). We have 3 clinical trials are going in Taiwan by now. In future, we will have established the PIC/S GMP grade stem cell preparation factory (15,225 m2